Showing results (591-600 of 636) with videos related to

Sort By:
Pageof 64
Circulation|March 19, 2019
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes MellitusEri T Kato, Michael G Silverman, Ofri Mosenzon, et al.
JAMA Cardiology|April 26, 2023
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER TrialPardeep S Jhund, Brian L Claggett, Atefeh Talebi, et al.
Journal of Cardiac Failure|December 17, 2023
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVERJawad H Butt, Karola Jering, Rudolf A DE Boer, et al.
European Heart Journal|March 30, 2020
Effects of dapagliflozin in DAPA-HF according to background heart failure therapyKieran F Docherty, Pardeep S Jhund, Silvio E Inzucchi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 16, 2026
A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HFAlasdair D Henderson, Kieran F Docherty, Atefeh Talebi, et al.
Journal of the American College of Cardiology|June 3, 2026
Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART AnalysisAlberto Foà, Maria A Pabon, Gerasimos Filippatos, et al.
Journal of the American College of Cardiology|November 9, 2024
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HFMingming Yang, Alasdair D Henderson, Atefeh Talebi, et al.
Journal of the American College of Cardiology|September 1, 2022
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection FractionJawad H Butt, Pooja Dewan, Pardeep S Jhund, et al.
Nature Medicine|December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.
JACC. Heart Failure|June 12, 2025
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction: A FINE-HEART AnalysisJohn W Ostrominski, Gerasimos Filippatos, Brian L Claggett, et al.
Pageof 64